quote:
Hi Luke
Thank you for your email clarifying the nature of your concerns.
I have discussed your email with the Council’s Registrar and the Professional Standards Advisor.
Pharmacists are able to ‘purchase, supply and promote any medicine, complementary therapy, herbal remedy or other healthcare product where there is no reason to doubt its quality or safety and when there is credible evidence of efficacy” (Code of Ethics (CoE) 2011 obligation 6.9).
As with many complementary or alternative “remedies” controversy surrounds “credible evidence of efficacy" with points of view ranging from sceptics to believers.
Pharmacists must also promote patient self-determination, respect patient’s rights, autonomy and freedom of choice (CoE Principle 2). Pharmacists cannot therefore, pressure or coerce a patient into purchasing any treatment or remedy, or use their position as a trusted health professional to influence a purchase. They must ensure the information they provide is impartial, relevant, up-to-date and independent of personal considerations (CoE obligation 2.4).
The patient makes the final informed decision about purchasing the treatment or remedy, be it complementary, herbal, alternative or homeopathic.
It is not Council’s responsibility to direct pharmacies as to what products they can stock. However, it is Council’s responsibility to remind pharmacists of their ethical obligations, which we will do in out next Newsletter.
Kind regards
Jenny Ragg
Deputy Registrar
Pharmacy Council of New Zealand
quote:
Hey Jenny,
Thanks again for replying.
I do accept that it's a controversial topic, and that many people whole-heartedly believe in its efficacy; but we don't base health policies on the beliefs of anyone. We conduct legitimate research, submit that research to peer-reviewed journals, and then others will try to replicate controversial findings, conduct meta-analyses etc.
I don't mean to sound condescending or like I'm saying anything you don't already know, but I'm just clarifying the point that if we conduct an honest review of the available scientific literature on the subject, it overwhelmingly fails to support any homeopathic claims, and to this day no homeopath has even theorised a verifiable mechanism for some of their claims, let alone recorded actual observations of it. So while controversy and ambiguity certainly exist within the public discourse, the actual available data paints a dominantly one-sided story.
But this story is not reflected at all, seemingly, in the Unichem branch. Here we not only have a plethora of products being offered, but they're sign-posted in their own area. Surely, we cannot deny that the average customer's perception of homeopathy is going to be influenced (if even only slightly) toward legitimacy, as a result of seeing this display. Pharmacists are highly educated and trained, so we trust them, we trust that the products being offered to us have been demonstrated to be safe, and effective.
So there is a fairly evident disconnect apparent to me, between the available pool of legitimate evidence, and the policy of at least this particular pharmacy. This disonnect ostensibly constitutes a breach of ((CoE) 2011 obligation 6.9). The product is being sold, and hasn't been proven as effective [beyond placebo], or even plausible. I understand and resolutely advocate the patient's right to autonomy and freedom of choice, but I really don't think that it's affected here. After all, as it stands today, the consumer's freedom of choice only exists within the pool of available products that have already been washed of ones considered unsafe or ineffective. My claim is that the ethical breach here warrants reclassifying homeopathy outside the pool, which has no effect on the consumer's freedom of choice for effective remedies.
When pharmacies take an at best ambivalent policy stance on unproven remedies, it creates an opportunity for unethical companies to use the public's inherent trust of the pharmacist to sell ineffective and potentially dangerous remedies. It's a very real threat to the public, and one which I worry isn't being contained by simply making an appearance in your newsletter.
Looking forward to your thoughts, and thanks for your time in this matter. I do believe that we all want what's best for the patient, so I'm just trying to understand your organisation's position on how that's being achieved in the status-quo, and how it is currently determined whether a product is fit for sale based on efficacy.
quote:
Hi Luke
Thank you for your further email. As the Council has addressed the public safety issue, that being our mandate, the Council has nothing further to add.
However, if you wish to make a complaint about a pharmacy service you are able to do so to the Health and Disability Commissioner. Please see my earlier email for the Commissioner’s contact details.
Kind regards
Jenny
Jenny Ragg
Deputy Registrar
Pharmacy Council of New Zealand
Well that went about as expected... onward and upward